Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anaptysbio Inc

23.70
+2.5612.11%
Post-market: 24.991.29+5.44%17:55 EDT
Volume:841.01K
Turnover:19.50M
Market Cap:696.32M
PE:-4.95
High:24.01
Open:21.29
Low:20.93
Close:21.14
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-TransMedics, Centrus Energy,  MongoDB

Reuters
·
05 Jun

Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May

Benzinga
·
05 Jun

Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires Live
·
04 Jun

BUZZ-AnaptysBio rises after H.C. Wainwright upgrades to 'buy' on arthritis drug progress

Reuters
·
04 Jun

AnaptysBio Shares up 2.7% Premarket After H.c. Wainwright Raises to Buy From Neutral

THOMSON REUTERS
·
04 Jun

AnaptysBio (ANAB) Receives a Hold from Truist Financial

TIPRANKS
·
04 Jun

AnaptysBio Raised to Buy From Neutral by HC Wainwright & Co.

Dow Jones
·
04 Jun

HC Wainwright Upgrades AnaptysBio to Buy From Neutral, $38 Price Target

MT Newswires Live
·
04 Jun

AnaptysBio Rise 6% After Results From Rheumatoid Arthritis Treatment Rosnilimab

Dow Jones
·
04 Jun

AnaptysBio announces investigational rosnilimab data

TIPRANKS
·
04 Jun

AnaptysBio Unveils Promising Six-Month Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis, Showcasing JAK-Like Efficacy and Favorable Safety Profile

Reuters
·
04 Jun

Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2B Trial in Ra

THOMSON REUTERS
·
04 Jun

AnaptysBio Is Maintained at Buy by Guggenheim

Dow Jones
·
28 May

Anaptys to Announce Updated Data From Phase 2B Trial of Rosnilimab, a Pd-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025

THOMSON REUTERS
·
28 May

AnaptysBio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Analysts Conflicted on These Healthcare Names: AnaptysBio (ANAB), Relay Therapeutics (RLAY) and Inspire Medical Systems (INSP)

TIPRANKS
·
07 May

AnaptysBio Is Maintained at Buy by Guggenheim

Dow Jones
·
06 May

AnaptysBio (ANAB) Receives a Buy from Wedbush

TIPRANKS
·
06 May

AnaptysBio price target raised to $54 from $52 at Guggenheim

TIPRANKS
·
06 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Relay Therapeutics (RLAY) and AnaptysBio (ANAB)

TIPRANKS
·
06 May